Mireinio a lleihau canlyniadau drwy ychwanegu cysyniadau cysylltiedig
100
Schistosomiasis
Cysyniad: | Schistosomiasis |
Pwysau: | 100% |
Parth: | Medicine and Dentistry |
83
Schistosoma Mansoni
Cysyniad: | Schistosoma Mansoni |
Pwysau: | 83% |
Parth: | Medicine and Dentistry |
83
Adult
Cysyniad: | Adult |
Pwysau: | 83% |
Parth: | Medicine and Dentistry |
65
Schistosoma
Cysyniad: | Schistosoma |
Pwysau: | 65% |
Parth: | Medicine and Dentistry |
48
Parasite (Microbiol...
Cysyniad: | Parasite (Microbiology) |
Pwysau: | 48% |
Parth: | Medicine and Dentistry |
47
Blood
Cysyniad: | Blood |
Pwysau: | 47% |
Parth: | Medicine and Dentistry |
44
Infection
Cysyniad: | Infection |
Pwysau: | 44% |
Parth: | Medicine and Dentistry |
38
Fluke
Cysyniad: | Fluke |
Pwysau: | 38% |
Parth: | Medicine and Dentistry |
36
Drug
Cysyniad: | Drug |
Pwysau: | 36% |
Parth: | Medicine and Dentistry |
36
Chemotherapeutic Ag...
Cysyniad: | Chemotherapeutic Agent |
Pwysau: | 36% |
Parth: | Medicine and Dentistry |
35
Development
Cysyniad: | Development |
Pwysau: | 35% |
Parth: | Medicine and Dentistry |
34
Vaccine
Cysyniad: | Vaccine |
Pwysau: | 34% |
Parth: | Medicine and Dentistry |
34
Neglected Tropical ...
Cysyniad: | Neglected Tropical Diseases |
Pwysau: | 34% |
Parth: | Medicine and Dentistry |
33
Antigen
Cysyniad: | Antigen |
Pwysau: | 33% |
Parth: | Medicine and Dentistry |
28
Anthelmintic
Cysyniad: | Anthelmintic |
Pwysau: | 28% |
Parth: | Medicine and Dentistry |
27
Epigenomics
Cysyniad: | Epigenomics |
Pwysau: | 27% |
Parth: | Medicine and Dentistry |
27
RNA Interference
Cysyniad: | RNA Interference |
Pwysau: | 27% |
Parth: | Medicine and Dentistry |
25
Selectivity Index
Cysyniad: | Selectivity Index |
Pwysau: | 25% |
Parth: | Medicine and Dentistry |
24
IC50
Cysyniad: | IC50 |
Pwysau: | 24% |
Parth: | Medicine and Dentistry |
24
Species
Cysyniad: | Species |
Pwysau: | 24% |
Parth: | Medicine and Dentistry |
49
Praziquantel
Cysyniad: | Praziquantel |
Pwysau: | 49% |
Parth: | Immunology and Microbiology |
46
Schistosomulum
Cysyniad: | Schistosomulum |
Pwysau: | 46% |
Parth: | Immunology and Microbiology |
43
Schistosoma
Cysyniad: | Schistosoma |
Pwysau: | 43% |
Parth: | Immunology and Microbiology |
38
Schistosoma Mansoni
Cysyniad: | Schistosoma Mansoni |
Pwysau: | 38% |
Parth: | Immunology and Microbiology |
28
Antigen
Cysyniad: | Antigen |
Pwysau: | 28% |
Parth: | Immunology and Microbiology |
24
IC50
Cysyniad: | IC50 |
Pwysau: | 24% |
Parth: | Immunology and Microbiology |
21
Schistosomiasis
Cysyniad: | Schistosomiasis |
Pwysau: | 21% |
Parth: | Immunology and Microbiology |
17
Parasite
Cysyniad: | Parasite |
Pwysau: | 17% |
Parth: | Immunology and Microbiology |
17
Worm
Cysyniad: | Worm |
Pwysau: | 17% |
Parth: | Immunology and Microbiology |
15
Development
Cysyniad: | Development |
Pwysau: | 15% |
Parth: | Immunology and Microbiology |
15
Selectivity Index
Cysyniad: | Selectivity Index |
Pwysau: | 15% |
Parth: | Immunology and Microbiology |
12
Immunoglobulin E
Cysyniad: | Immunoglobulin E |
Pwysau: | 12% |
Parth: | Immunology and Microbiology |
11
Surface Property
Cysyniad: | Surface Property |
Pwysau: | 11% |
Parth: | Immunology and Microbiology |
10
Cercaria
Cysyniad: | Cercaria |
Pwysau: | 10% |
Parth: | Immunology and Microbiology |
10
Trematoda
Cysyniad: | Trematoda |
Pwysau: | 10% |
Parth: | Immunology and Microbiology |
9
Blood Plasma
Cysyniad: | Blood Plasma |
Pwysau: | 9% |
Parth: | Immunology and Microbiology |
9
Epigenetics
Cysyniad: | Epigenetics |
Pwysau: | 9% |
Parth: | Immunology and Microbiology |
9
Host
Cysyniad: | Host |
Pwysau: | 9% |
Parth: | Immunology and Microbiology |
8
Synthesis
Cysyniad: | Synthesis |
Pwysau: | 8% |
Parth: | Immunology and Microbiology |
7
Morphology
Cysyniad: | Morphology |
Pwysau: | 7% |
Parth: | Immunology and Microbiology |
43
Praziquantel
Cysyniad: | Praziquantel |
Pwysau: | 43% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
40
Schistosomiasis
Cysyniad: | Schistosomiasis |
Pwysau: | 40% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
28
Schistosoma
Cysyniad: | Schistosoma |
Pwysau: | 28% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
26
Schistosomulum
Cysyniad: | Schistosomulum |
Pwysau: | 26% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
25
EC50
Cysyniad: | EC50 |
Pwysau: | 25% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
19
Schistosoma Mansoni
Cysyniad: | Schistosoma Mansoni |
Pwysau: | 19% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
19
Worm
Cysyniad: | Worm |
Pwysau: | 19% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
17
Anthelmintic Agent
Cysyniad: | Anthelmintic Agent |
Pwysau: | 17% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
13
Quinoxaline
Cysyniad: | Quinoxaline |
Pwysau: | 13% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
13
Trematode
Cysyniad: | Trematode |
Pwysau: | 13% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
12
Drug
Cysyniad: | Drug |
Pwysau: | 12% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
11
Infection
Cysyniad: | Infection |
Pwysau: | 11% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
10
Chemotherapy
Cysyniad: | Chemotherapy |
Pwysau: | 10% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
10
Bacterium
Cysyniad: | Bacterium |
Pwysau: | 10% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
8
N Acylhomoserine La...
Cysyniad: | N Acylhomoserine Lactone |
Pwysau: | 8% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
8
Thiolactone
Cysyniad: | Thiolactone |
Pwysau: | 8% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
7
Fasciola Hepatica
Cysyniad: | Fasciola Hepatica |
Pwysau: | 7% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
7
Parasite
Cysyniad: | Parasite |
Pwysau: | 7% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
6
Human
Cysyniad: | Human |
Pwysau: | 6% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
6
Homoserine
Cysyniad: | Homoserine |
Pwysau: | 6% |
Parth: | Pharmacology, Toxicology and Pharmaceutical Science |
Canfuwyd 10 o arbenigwyr gydag allbwn ymchwil yn gysylltiedig i'r holl gysyniadau a ddewiswyd
Ystod Allbwn Ymchwil